Related by context. All words. (Click for frequent words.) 70 GW# [003] 70 Torisel temsirolimus 70 microtubule inhibitor 69 Aviptadil 69 Lipid lowering 69 erlotinib Tarceva ® 69 thalidomide Thalomid 69 paclitaxel Taxol 69 trastuzumab Herceptin 68 cetuximab Erbitux ® 68 Vidaza azacitidine 68 nucleotide analogue 68 vinca alkaloid 68 histone deacetylase inhibitor 68 benzimidazole 68 trastuzumab Herceptin ® 68 erlotinib Tarceva 68 Squalamine 68 anti angiogenic agents 68 cytostatic 67 lenalidomide Revlimid 67 anthracyclines taxanes 67 gastrointestinal stromal tumors GISTs 67 Cloretazine 67 Velcade bortezomib 67 docetaxel Taxotere ® 67 MAGE A3 ASCI 67 bevacizumab Avastin ® 67 Roche Xeloda 67 alkylating agent 66 relapsed ovarian cancer 66 sorafenib Nexavar 66 IAP inhibitors 66 chimeric monoclonal antibody 66 LHRH receptor positive 66 taxane chemotherapy 66 lapatinib Tykerb 66 receptor tyrosine kinase inhibitor 66 Plaquenil 66 cisplatin gemcitabine 66 Tarceva TM 66 immune modulating 66 IgG1 monoclonal antibody 66 Gilead Viread 65 ALK inhibitors 65 Gleevec imatinib 65 malignant ascites 65 Sustiva efavirenz 65 metastatic colorectal 65 demonstrated antitumor activity 65 dasatinib Sprycel ® 65 Noxafil 65 dasatinib Sprycel 65 antiepileptics 65 tyrosine kinase inhibitors TKIs 65 haematological malignancies 65 IMiDs ® 65 Anti VEGF 65 Pemetrexed 65 galiximab 65 fibrate drugs 65 tubulin binding 65 LymphoStat B TM 65 HERCEPTIN 65 M2 subunit 65 sodium stibogluconate 65 lymphoid malignancies 65 refractory chronic lymphocytic 65 IMiDs R 65 doxorubicin Adriamycin 64 Lilly Gemzar 64 antiangiogenic agent 64 Nexavar sorafenib 64 antihormonal 64 induced anemia 64 bevacizumab Avastin 64 anthracycline chemotherapy 64 gabapentin Neurontin 64 antimitotic 64 antisense inhibitors 64 Anidulafungin 64 hormone refractory metastatic prostate 64 nucleoside analog 64 signal transduction inhibitors 64 Aflibercept 64 Afatinib 64 nonsteroidal 64 alkylating agents 64 gemcitabine Gemzar 64 hypereosinophilic syndrome 64 proteasome inhibitor 64 bortezomib Velcade R 64 Cancidas 64 imatinib Gleevec 64 NMDA antagonists 64 immunological diseases 64 Abacavir 64 Temodar temozolomide 64 Pyridorin 64 multitargeted 64 Muraglitazar 64 hormone LHRH antagonist 64 nucleoside analogues 64 Marqibo TM 64 alkylating 64 ADVEXIN therapy 64 docetaxel Taxotere 64 selective modulator 64 Dacogen decitabine 64 Enzastaurin 64 relapsed ALL 64 gemcitabine Gemzar ® 64 AKT inhibitor 64 cetuximab Erbitux 64 Panzem R NCD 64 Cloretazine R 64 pertuzumab 64 Bevacizumab Avastin 64 ixabepilone 64 ZOLINZA 64 Protease inhibitor 64 neoadjuvant setting 64 OMP #M# 63 mutated KRAS gene 63 UPLYSO 63 nucleoside reverse transcriptase inhibitor 63 tenofovir Viread 63 ASONEP ™ 63 cardiotoxic 63 JAK2 inhibitor 63 EGFR tyrosine kinase inhibitors 63 papillary renal cell carcinoma 63 TKI therapy 63 kidney urologic 63 nelfinavir Viracept 63 antineoplastic 63 Tyrima 63 anthracycline containing 63 radiolabeled TM# 63 radioimmunotherapy RIT 63 immuno modulatory 63 Darinaparsin 63 Alimta pemetrexed 63 subcutaneous immunoglobulin 63 Dalbavancin 63 antiresorptive 63 pediatric acute lymphoblastic 63 paclitaxel Taxol ® 63 BEXXAR Therapeutic Regimen 63 Revlimid lenalidomide 63 Sutent sunitinib 63 Onconase 63 antifibrotic 63 HCV polymerase 63 Proellex TM 63 TLR9 agonist 63 intranasal formulation 63 liposomal doxorubicin 63 blood clot dissolving 63 K ras mutations 63 Zarnestra 63 MGN# 63 acadesine 63 nucleoside analogs 63 Mitomycin C 63 Zometa zoledronic acid 63 chemotherapeutic regimen 63 fosbretabulin 63 Paraplatin ® 63 aromatase inhibitors AIs 63 Pertuzumab 63 alefacept 63 histone deacetylase HDAC inhibitors 63 fluoro sorafenib 63 flutamide 63 orally administered inhibitor 63 Davanat 63 vascular disrupting agents 63 either acutely decompensated 63 Irinotecan 63 liposomal formulation 63 CEQ# 63 treating neuropathic pain 63 Panzem NCD 63 Peginterferon alfa 2b 63 alvespimycin 63 generation purine nucleoside 63 cetuximab Erbitux R 63 idarubicin 63 vemurafenib 63 pegylated liposomal doxorubicin 63 abacavir Ziagen 63 Gleevec imatinib mesylate 63 Carbamazepine 63 investigational therapies 63 paclitaxel Taxol R 63 Trovax 63 gastrointestinal stromal tumors GIST 63 acyclovir Lauriad R 63 myelodysplastic myeloproliferative diseases 63 Gemzar gemcitabine 62 immunomodulatory agents 62 Ceflatonin 62 Epivir HBV 62 Aplidin 62 Proxinium TM 62 Taxotere chemotherapy 62 Aromasin exemestane 62 Familial Adenomatous Polyposis FAP 62 Rituxan rituximab 62 XYOTAX TM 62 inhibitor RG# 62 radiotherapeutic 62 tamoxifen Nolvadex ® 62 targeted antifolate 62 SinuNase TM 62 recurrent glioblastoma multiforme 62 Antiarrhythmic 62 temozolomide TMZ 62 metaglidasen 62 metastatic malignant 62 nilotinib Tasigna 62 G#DT 62 benign prostatic hypertrophy BPH 62 cyclophilin inhibitors 62 novel emulsion formulation 62 efalizumab 62 COPEGUS R 62 adalimumab Humira 62 demethylating agent 62 aurora kinase 62 FUSILEV enhances 62 relapsed MM 62 recurrent metastatic 62 MKC# MT 62 TORISEL TM 62 myelofibrosis polycythemia vera 62 Mepact 62 Tigecycline 62 anticancer compound 62 CYT# potent vascular disrupting 62 NEUGENE 62 multiple myeloma MM 62 Kit CD# positive 62 Arranon 62 orally disintegrating 62 lymphomas leukemias 62 Liprotamase 62 Platinol ® cisplatin 62 rosiglitazone maleate 62 Sudhir Agrawal D.Phil 62 statins cholesterol lowering 62 Femara letrozole 62 Thiovir 62 stavudine d4T 62 murine models 62 PI3K/Akt pathway inhibitor 62 cisplatin chemotherapy 62 endocrine therapies 62 uridine triacetate 62 antifolates 62 monoclonal antibody mAb 62 boosted protease inhibitor 62 pharmacologically active isomer 62 lenalidomide dexamethasone 62 IMA# 62 histone deacetylase HDAC 62 Immunotherapeutic 62 ergot alkaloids 62 tanespimycin 62 paclitaxel poliglumex 62 induced hepatotoxicity 62 EGFR HER2 62 unresectable tumors 62 antiandrogen 62 potent cytotoxic 62 non nucleoside 62 novel VDA molecule 62 Protease inhibitors 62 lenalidomide Revlimid R 62 Cabazitaxel 62 CINOD 62 antiplatelet medications 62 Taxol paclitaxel 62 Camptosar ® 62 Posiphen TM 62 RNA antagonists 62 AstraZeneca Iressa 62 palliative radiotherapy 62 aspirin clopidogrel 62 Rimantadine 62 protease inhibitor PI 62 antimetabolite 62 mapatumumab 62 mutated K ras 62 EGFR inhibitors 62 administered intranasally 62 anastrazole 62 polycythemia vera PV 62 Lenalidomide 62 zidovudine AZT 62 histamine dihydrochloride 62 PrevOnco 62 pentostatin 62 SERMs 62 gemcitabine carboplatin 62 HCV protease inhibitors 62 endothelin receptor antagonists 62 TransMID TM 62 Cx# [002] 62 #I TM# 62 imatinib Gleevec ® 62 Epidermal Growth Factor Receptor 62 erythropoietic 62 ritonavir boosted protease inhibitor 62 protein tyrosine phosphatase 1B 62 long acting bronchodilator 62 Surgical resection 62 aripiprazole Abilify 62 ß blockers 62 Aplidin R 61 Remicade infliximab 61 pain palliation 61 rivastigmine Exelon 61 denileukin diftitox 61 AZT zidovudine Retrovir 61 potent anticancer 61 3TC lamivudine Epivir 61 Bayer Onyx 61 temsirolimus Torisel ® 61 riociguat 61 radiolabeled 61 Intravenous CP 61 metastatic neuroendocrine tumors 61 auristatin 61 fusion enhancers 61 lamotrigine Lamictal 61 antiproliferative effects 61 adriamycin 61 chemo immunotherapy 61 rifamycin 61 VivaGel ™ 61 immunotoxin 61 treat enlarged prostate 61 trastuzumab Herceptin R 61 TNF blocker 61 Pharmacokinetics PK 61 microwave hyperthermia 61 oral prodrug 61 Foradil Aerolizer 61 prokinetic agent 61 Pafuramidine 61 infliximab Remicade 61 Cytoxan 61 Clolar ® 61 tumor subtypes 61 Vandetanib 61 MCSP respectively 61 pancreatic enzyme replacement 61 Pegylated Interferon 61 Monoclonal antibody 61 cholesteryl ester transfer 61 docetaxel Taxotere R 61 Cloretazine VNP#M 61 Xeloda capecitabine 61 finasteride Proscar 61 Sebivo 61 CellCept mycophenolate mofetil 61 Modrenal 61 humanized antibody 61 refractory colorectal cancer 61 Zybrestat 61 containing LABAs 61 Annamycin 61 infused intravenously 61 chemopreventive agents 61 MEK inhibitors 61 HuLuc# 61 BRAF mutant 61 investigational monoclonal antibody 61 non hodgkin lymphoma 61 angiotensin receptor 61 sublingual tablets 61 highly selective inhibitor 61 indinavir Crixivan 61 Imatinib mesylate 61 peptide antigens 61 brivanib 61 humanized monoclonal antibodies 61 Oncolytic 61 trans retinoic acid ATRA 61 taxane therapy 61 chemotherapy hormonal therapy 61 Novartis Diovan 61 proliferative disorders 61 MyVax R 61 Xanafide 61 IMC #B 61 fluoropyrimidine 61 Arimidex anastrozole 61 Pfizer Camptosar 61 NSCLC tumors 61 direct thrombin inhibitors 61 novel immunomodulatory 61 containing abacavir 61 polycythemia vera essential thrombocythemia 61 vapreotide acetate 61 ATL# [001] 61 fulvestrant 61 azacytidine 61 gemtuzumab ozogamicin 61 Helicobacter pylori eradication 61 pegylated alpha interferon 61 Li Fraumeni Syndrome 61 albumin bound paclitaxel 61 NS#/#A protease 61 IL# PE 61 atazanavir Reyataz 61 Alequel 61 protease inhibitors PIs 61 ovarian breast 61 oropharyngeal candidiasis OPC 61 SPRYCEL ® 61 busulfan 61 MGd 61 molecularly targeted 61 Serostim ® 61 letrozole Femara 61 transthyretin amyloidosis 61 Progressive Multifocal Leukoencephalopathy 61 Dementia Related Psychosis 61 Luteinizing Hormone Releasing Hormone 61 PKC# 61 histologies 61 ritonavir boosted 61 myeloproliferative disorders 61 c KIT 61 IAP inhibitor 61 Cardiotoxicity 61 HepDirect prodrug 61 human IgG1 monoclonal 61 renoprotective 61 novel anticancer 61 mercaptopurine 61 maximally tolerated lipid lowering 61 Romiplostim 61 Estrogen Receptor 61 constipation OIC 61 antiangiogenic therapy 61 pregabalin Lyrica 61 cyclophosphamide methotrexate 60 capsular polysaccharide 60 immune suppressive 60 Onrigin 60 efavirenz EFV 60 MetMAb 60 hyaluronidase enzyme 60 overlapping toxicities 60 vorinostat 60 Collategene 60 alpha 2a 60 mitochondrial toxicity 60 Doxil ® 60 Cyclosporin 60 metastatic hormone refractory 60 intensive lipid lowering 60 IGF IR 60 mycophenolate mofetil MMF 60 Erlotinib 60 Gleevec resistant 60 ALK inhibitor 60 TLR9 agonists 60 Fondaparinux 60 pan HDAC inhibitor 60 anti secretory 60 Egrifta 60 Novartis Gleevec 60 Virulizin ® 60 paclitaxel cisplatin 60 lipid lowering therapies 60 Sprycel dasatinib 60 Temodar ® 60 ocular disorders 60 genotypic resistance 60 recurrent glioblastoma multiforme GBM 60 taxotere 60 Tasigna nilotinib 60 essential thrombocythemia ET 60 mTOR inhibitors 60 multidrug 60 intra abdominal infections 60 OMP #R# 60 Crixivan 60 T#I [002] 60 nucleoside reverse transcriptase inhibitors 60 Taxotere ® 60 luteinizing hormone releasing 60 anti hypertensives 60 refractory Hodgkin 60 DCCR 60 Bayer Nexavar 60 CINTREDEKIN BESUDOTOX 60 recombinant interferon 60 Starlix 60 rosuvastatin Crestor 60 sunitinib Sutent 60 PDE4 inhibitors 60 proteasome inhibitors 60 CCR5 inhibitor 60 metastatic bladder 60 Recombinant interferon alpha 60 polymerase inhibitors 60 Immunomodulatory 60 OncoVex 60 haematologic malignancies 60 alpha1 antitrypsin deficiency 60 antiemetics 60 calcineurin inhibitor 60 basiliximab 60 antibiofilm 60 pyridostigmine 60 raloxifene Evista 60 metastatic malignant melanoma 60 FK# 60 fallopian tube carcinoma 60 syngeneic 60 cytotoxic therapy 60 gemcitabine chemotherapy 60 abacavir lamivudine 60 leukotriene receptor antagonist 60 OvaRex MAb 60 concurrent chemoradiation 60 ATL# [002] 60 cytotoxic effects 60 immunotherapeutic vaccine 60 ribonucleotide reductase clinically validated 60 carmustine 60 Dasatinib 60 ribavirin RBV 60 NS5b 60 catheter occlusion 60 Antiangiogenic 60 CCR5 receptor antagonist 60 antidiabetic drugs 60 MDS AML 60 RNAi therapeutic targeting 60 DNA intercalator 60 HGS# 60 topiramate Topamax 60 Adjuvant chemotherapy 60 THR beta agonist 60 aerosolized AAT 60 pyrazinamide 60 Apaziquone 60 refractory metastatic 60 adipiplon 60 mda 7 60 valacyclovir Valtrex 60 Initiate Clinical Trial 60 predictive biomarkers 60 ALN HPN 60 tropism testing 60 tigecycline 60 basal cell carcinoma BCC 60 factor TNF 60 androgen receptor antagonist 60 anti tubercular 60 immune modulatory 60 vinorelbine tartrate 60 rituximab Rituxan 60 intra arterial chemotherapy 60 LymphoStat B belimumab 60 HepaGam B 60 enzyme inhibitor 60 Viread tenofovir disoproxil fumarate 60 Telzir 60 epirubicin 60 HQK 60 metformin sulphonylurea 60 Inegy 60 neuro inflammatory 60 Roche Herceptin 60 alfa 2a 60 systemically administered 60 Proquin XR 60 immunotoxins 60 anti idiotype 60 HER2 positive metastatic breast 60 potently inhibit 60 Fludarabine 60 PEGylated anti 60 immunomodulatory therapies 60 ALV# 60 administered intraperitoneally 60 TransMID 60 metastatic gastric 60 immunodeficiency disorders 60 VEGF inhibitors 60 peginterferon alpha 2a 60 HSP# inhibitor 60 Hedgehog Pathway Inhibitor 60 echinocandins 60 genomic biomarker 60 inhibit replication 60 Enbrel Humira 60 Amgen Neulasta ® 60 inhaled bronchodilators 60 antiestrogen 60 eflornithine 60 HCV replicon 60 HyperAcute 60 GPR# agonists 60 pulmonary hypertension PH 60 pegylated interferon alfa 2a 60 eribulin mesylate 60 BrachySil TM 60 HGS ETR2 60 mRCC 60 CCR5 antagonist 60 cidofovir 60 acyclovir Zovirax 60 anti TNFa 60 invasive candidiasis 60 TAFA# 60 piroxicam 60 Actimmune ® 60 Cyclosert 59 SIR Spheres 59 Copegus ribavirin 59 pegylated interferon alfa 59 pyrimethamine 59 DCVax R 59 INFERGEN 59 pharmacologic stress 59 saline placebo 59 antitumour 59 immunomodulation 59 intravenous tissue plasminogen 59 biologic DMARDs 59 Onalta TM 59 immunosuppressive therapies 59 FLT3 59 Mitoxantrone 59 protein kinase inhibitor 59 cardiometabolic disorders 59 myeloproliferative diseases 59 Removab 59 superficial basal cell carcinoma 59 endogenous ligands 59 malignant lymphomas 59 Pathway Inhibitor 59 Etravirine 59 haematologic 59 PhG alpha 1 59 bladder ovarian 59 synthetic analogues 59 cilengitide 59 huC# DM4 59 danazol 59 antirheumatic 59 desmopressin acetate 59 accumulate preferentially 59 mycophenolate mofetil 59 diagnostic biomarker 59 tenofovir emtricitabine 59 PNP inhibitor 59 DMARDS 59 Temozolomide 59 atypical hemolytic uremic syndrome 59 Multidrug 59 tinidazole 59 targeted radiotherapeutic 59 metastatic GIST 59 virus HCV protease inhibitor 59 anti androgens 59 Herceptin trastuzumab 59 tiuxetan 59 investigational protease inhibitor 59 temozolomide Temodar 59 Factor VIIa 59 G6PD deficiency 59 TASKi3 59 PORxin 59 acetonide FA 59 recurrent NSCLC 59 nodal metastasis 59 monoclonal anti 59 non nucleoside inhibitor 59 lipid lowering agents 59 liposome formulation 59 indinavir 59 Didanosine 59 weekly subcutaneous injections 59 Epivir 59 commercialize deforolimus 59 orally inhaled 59 FOLFOX chemotherapy 59 statin cholesterol lowering 59 treatmentof 59 including eniluracil ADH 59 biliary tract cancer 59 pioglitazone hydrochloride 59 Trastuzumab Herceptin 59 metformin XR 59 Doribax 59 Melphalan 59 prostate carcinoma 59 ovarian endometrial 59 cellular immunotherapy 59 Daptomycin 59 Elotuzumab 59 Degarelix 59 mycosis fungoides 59 ISTODAX 59 novel immunotherapeutic 59 PSN# [002] 59 BCG refractory 59 oral rivaroxaban 59 adefovir dipivoxil 59 preclinically 59 radioprotective 59 chemosensitizer 59 stage chemoresistant ovarian 59 histone deacetylases 59 goserelin 59 DNA hypermethylation 59 TLR8 agonist 59 oblimersen 59 anti CD# antibodies 59 Losartan 59 chemopreventive agent 59 JAK2 inhibitors 59 Propecia finasteride 59 urothelial cancer 59 HDAC Inhibitor 59 epigenetic therapies 59 Intelence 59 anti PlGF 59 Aurora kinase inhibitor 59 tryptase 59 cisplatin resistant 59 steroid refractory 59 Platinol 59 Factor Xa inhibitors 59 AZILECT R 59 CDK cyclin dependent 59 imatinib resistance 59 secondary amenorrhea 59 intravenous immunoglobulin IVIg 59 Angiolix 59 Evoltra ® 59 daptomycin 59 immunomodulatory therapy 59 MVA MUC1 IL2 59 multicenter Phase II 59 GARDASIL ® 59 Gamunex C 59 EGFR TKIs 59 GRNOPC1 contains 59 Riluzole 59 AEG# 59 retinoic acid receptor 59 teratogenic effects 59 non selective NSAIDs 59 radionuclide therapy 59 acid phosphatase PAP 59 antibody MAb 59 herceptin 59 Naive Patients 59 Hodgkin lymphoma HL 59 Phase Ib IIa clinical 59 oral hypoglycemic 59 Campath alemtuzumab 59 melphalan prednisone 59 tipranavir ritonavir 59 depsipeptide 59 CDDO Im 59 davalintide 59 compound AEZS 59 Hepatocellular Carcinoma HCC 59 prostate cancer CRPC 59 dyslipidemias 59 chemotherapeutic regimens 59 MYCAMINE 59 gastrointestinal stromal tumors 59 MAGE A3 protein 59 pancreatic neuroendocrine tumors 59 cathepsins 59 selective adenosine 59 elvitegravir 59 ticagrelor Brilinta 59 prostate carcinomas 59 forodesine 59 nonnucleoside reverse transcriptase inhibitors 59 Myolimus 59 hoFH 59 Quinamed 59 Insegia 59 oral antidiabetes drugs 59 chronic myeloid 59 Preclinical studies suggest 59 combretastatin A4 phosphate CA4P 59 oncolytic virus therapies 59 immune suppressants 59 mycophenolate 59 r hGH 59 sodium thiosulfate STS 59 hyperplasia BPH 59 KRAS oncogene 59 quinoline 59 chronic eosinophilic leukemia 59 Edurant 59 iobenguane 59 somatostatin analogues 59 emtricitabine FTC 59 LNP formulations 58 Fabry Disease 58 Personalized Immunotherapy 58 mild hepatic impairment 58 docetaxel chemotherapy 58 colon carcinoma 58 topical formulations 58 Isentress raltegravir 58 Perforomist ™ Inhalation Solution 58 Platinol ® 58 metastatic uveal melanoma 58 TNF alpha antagonist 58 BRCA1 BRCA2 58 homotaurine 58 insulin sensitizing 58 Zelapar 58 systemic fungal infections 58 Capecitabine 58 cytoprotective 58 refractory CLL 58 visilizumab 58 receptor inhibitors 58 paroxetine Paxil 58 efavirenz Sustiva 58 CDK inhibitor 58 inhibit EGFR 58 Tesmilifene 58 adjuvant cisplatin 58 T1c 58 vinorelbine 58 adeno associated viruses 58 pravastatin Pravachol 58 tumor necrosis 58 morpholino 58 antimetastatic 58 vidofludimus 58 antitumoral 58 chronic thromboembolic pulmonary 58 tuberous sclerosis TS 58 CYP#D# inhibitor 58 platelet inhibitor 58 ORENCIA ® 58 selective inhibition 58 refractory acute myeloid 58 Antitumor 58 thromboembolic disease 58 Rilonacept 58 KRAS mutation 58 skeletal metastases 58 posaconazole 58 vaginal candidiasis 58 antihyperglycemic 58 Archexin 58 Anticalins ® 58 d4T stavudine Zerit 58 pan genotypic 58 interferon alfa 2b 58 GRNVAC1 58 CIMZIA TM certolizumab pegol 58 metastatic renal 58 infusional 58 JAK inhibitor 58 lamivudine resistant 58 bicalutamide 58 bovine thrombin 58 refractory gastrointestinal stromal 58 cranial irradiation 58 pretransplant 58 enoxaparin Lovenox 58 therapeutic monoclonal antibody 58 pancreatic prostate 58 antisense compounds 58 prodrugs 58 Actinic Keratosis 58 gastrointestinal stromal tumor GIST 58 Kantarjian 58 anti cholinesterase 58 Glycopyrrolate 58 cardiac glycosides 58 oncolytic 58 Imuran 58 novel therapeutic antibodies 58 treat chronic sinusitis 58 Myelodysplastic Syndrome MDS 58 myeloablative 58 CBLC# 58 NuMimetic TM 58 INTELENCE 58 cutaneous T 58 varenicline Chantix 58 cMET 58 GnRH antagonist 58 emulsion formulations 58 prostate cancer HRPC 58 Combination therapy 58 HAART regimens 58 sunitinib malate 58 allogeneic hematopoietic cell 58 NPC 1C 58 beta estradiol 58 standard chemotherapy regimens 58 mutated p# 58 lamivudine 3TC 58 radiolabeled monoclonal antibody 58 nevirapine Viramune 58 irinotecan chemotherapy 58 hydroxamic acid 58 relapsed leukemia 58 phosphodiesterase inhibitors 58 carbohydrate polymer 58 Commonly prescribed 58 5 HT2C 58 prostate cancer mCRPC 58 Chemotherapeutic 58 colorectal lung 58 antihypertension 58 Aganocide ® 58 untreated metastatic pancreatic 58 immuno suppressant 58 unexplained vaginal bleeding 58 metastatic lymph nodes 58 LHRH analogues 58 GeneICE 58 anti angiogenic drugs 58 beta2 agonist 58 selective agonists 58 CB1 antagonists 58 genomic biomarkers 58 β blockers 58 selectively inhibited 58 Fc gamma receptor 58 darbepoetin alfa Aranesp 58 CD8 + cytotoxic 58 rhIGF-I/rhIGFBP-3 58 Li Fraumeni 58 protein kinase inhibitors 58 torsade de pointes 58 exocrine pancreatic insufficiency EPI 58 topical ocular 58 Myelodysplastic syndromes MDS 58 alpha#beta# 58 ganciclovir 58 enzyme inhibitors 58 IgG1 antibody 58 inhibit metastasis 58 chemoresistant 58 Tarceva erlotinib 58 Targretin capsules 58 antidepressants SSRIs 58 Kinoid 58 RRM1 58 sigma receptor 58 Sapacitabine 58 Therapeutic Vaccine 58 chlamydial 58 surgically resectable 58 metformin sulfonylurea 58 preclinical efficacy 58 antiobesity 58 prophylactic preventive 58 heparin induced thrombocytopenia 58 pimozide 58 TransVax ™ 58 patients undergoing chemotherapy 58 urothelial bladder cancer 58 Tazorac 58 VIBEX MTX 58 Truvada Viread 58 intravenous iv 58 NRTI backbone 58 SSc 58 curative surgical resection 58 ENMD # 58 tumor specific antigen 58 Parnate 58 Diamyd r 58 Epothilones 58 Initiates Phase III 58 ciprofloxacin Cipro 58 fibrinolytic 58 novel peptide 58 Theratope 58 fludarabine 58 systemic ALCL